162 related articles for article (PubMed ID: 10758022)
1. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications.
Miller LG; Hays RD
AIDS Read; 2000 Mar; 10(3):177-85. PubMed ID: 10758022
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
Turner BJ
J Infect Dis; 2002 May; 185 Suppl 2():S143-51. PubMed ID: 12001036
[TBL] [Abstract][Full Text] [Related]
4. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
5. [Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].
Slama L; Le Camus C; Amiel C; Pialoux G; Gharakhanian S
Med Mal Infect; 2006 Jan; 36(1):16-26. PubMed ID: 16325363
[TBL] [Abstract][Full Text] [Related]
6. When and where to start: guidelines for the initiation of antiretroviral therapy.
Volberding P
AIDS Read; 2000 Mar; 10(3):150-5; discussion 171-4. PubMed ID: 10758014
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
8. Determinants of virological response to antiretroviral therapy: implications for long-term strategies.
Deeks SG
Clin Infect Dis; 2000 Jun; 30 Suppl 2():S177-84. PubMed ID: 10860903
[TBL] [Abstract][Full Text] [Related]
9. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
10. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
Fairley CK; Permana A; Read TR
HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
[TBL] [Abstract][Full Text] [Related]
11. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study.
Rathbun RC; Farmer KC; Stephens JR; Lockhart SM
Clin Ther; 2005 Feb; 27(2):199-209. PubMed ID: 15811483
[TBL] [Abstract][Full Text] [Related]
12. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
[TBL] [Abstract][Full Text] [Related]
13. Attaining higher goals in HIV treatment: the central importance of adherence.
Friedland GH; Williams A
AIDS; 1999 Sep; 13 Suppl 1():S61-72. PubMed ID: 10546786
[TBL] [Abstract][Full Text] [Related]
14. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial.
Weber R; Christen L; Christen S; Tschopp S; Znoj H; Schneider C; Schmitt J; Opravil M; Günthard HF; Ledergerber B;
Antivir Ther; 2004 Feb; 9(1):85-95. PubMed ID: 15040540
[TBL] [Abstract][Full Text] [Related]
15. HIV drug resistance and the other causes of treatment failure.
Schouten JT
STEP Perspect; 1997; 9(3):5-8. PubMed ID: 11364937
[TBL] [Abstract][Full Text] [Related]
16. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
[TBL] [Abstract][Full Text] [Related]
17. Predicting and monitoring antiretroviral adherence.
Gross R
LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
[TBL] [Abstract][Full Text] [Related]
18. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.
Adjé-Touré CA; Cheingsong R; Garcìa-Lerma JG; Eholié S; Borget MY; Bouchez JM; Otten RA; Maurice C; Sassan-Morokro M; Ekpini RE; Nolan M; Chorba T; Heneine W; Nkengasong JN
AIDS; 2003 Jul; 17 Suppl 3():S49-54. PubMed ID: 14565609
[TBL] [Abstract][Full Text] [Related]
20. Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.
Nieuwkerk P; Gisolf E; Sprangers M; Danner S;
Antivir Ther; 2001 Jun; 6(2):97-103. PubMed ID: 11491422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
